Truist Financial, Leerink partners, and Morgan Stanley have raised price targets and weighed in on Incyte stock.
5 reports, 2 independent
Updated Oct 24
Gone quiet
- Reports
- 5
- Developments
- 3
- Repetition
- 40%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial, Leerink partners, and Morgan Stanley have raised price targets and weighed in on Incyte stock.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.New firms, Fifth Third and Mizuho, added to the analyst coverage of Incyte stock.1 source
Morgan Stanley set a price objective on Incyte, and Cantor Fitzgerald reaffirmed its rating.1 source
Analysts raised price targets for Incyte stock from various firms.1 source
Keep exploring
The entities involved
-
Incyte
American pharmaceutical company
Nothing else this week.
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
-
Morgan Stanley
U.S. investment bank
Related events
- Truist Financial decreased its price target on Brunswick Corporation, while Morgan Stanley also set a target price for the company.
- Multiple financial institutions, including Morgan Stanley, Citigroup, and TD Cowen, boosted price targets and upgraded ratings on October 16, 2026.
- Financial institutions including Truist Financial, Royal Bank of Canada, Bank of America, and TD Securities raised price targets on October 23, 2026.
- Royal Bank of Canada, Citigroup, and Morgan Stanley issued price target and rating updates on August 27, 2026.
- Truist Financial, Citigroup, and TD Cowen updated their price targets for Clean Harbors stock on October 31, 2026.